**Bill Analysis: HR 6109**
HR 6109 aims to amend the Social Security Act, specifically targeting Medicare Advantage plans' prior authorization coverage determinations. The bill establishes new regulations for these plans, which could significantly impact the healthcare industry.
**New Regulations:**
The bill introduces a new requirement (Section 1857(e)(6)) that sets an "allowable rate" of reversed prior authorization coverage determinations. If a Medicare Advantage plan exceeds this rate, the Secretary may terminate the contract with respect to that plan. The allowable rate is defined as:
* More than 25% of initial denials being later reconsidered and reversed
* A significant reduction in the number of reconsidered and reversed prior authorizations compared to the previous year
**Affected Industries:**
The bill primarily affects Medicare Advantage plans, which are offered by private insurance companies. These plans will need to adapt to the new regulations, potentially requiring changes to their prior authorization processes.
**Compliance Requirements and Timelines:**
* The new requirements apply to plan years beginning on or after one year from the date of enactment.
* Plans must ensure that they do not exceed the allowable rate of reversed prior authorizations. Failure to comply may result in contract termination.
**Enforcement Mechanisms and Penalties:**
The Secretary has the authority to terminate contracts with Medicare Advantage plans that fail to meet the new requirements. This could lead to significant financial losses for non-compliant plans.
**Economic and Operational Impacts:**
* The bill may lead to increased administrative costs for Medicare Advantage plans, as they implement changes to their prior authorization processes.
* Plans may need to invest in new technologies or staff training to ensure compliance with the new regulations.
* Patients may benefit from reduced barriers to care, as plans are incentivized to approve more prior authorizations.
**Monied Interest Analysis:**
The bill's sponsors and cosponsors have received significant donations from healthcare-related PACs and organizations. For example:
* Rep. Pocan (D-WI), the primary sponsor, has received contributions from the American Medical Association, the National Association of Community Health Centers, and the Pharmaceutical Research and Manufacturers of America.
* Other cosponsors, such as Rep. Ocasio-Cortez (D-NY) and Rep. Schakowsky (D-IL), have also received donations from healthcare-related organizations.
While these donations do not necessarily imply quid pro quo, they highlight the complex web of interests at play in this legislation. The bill's passage may be influenced by the competing priorities of various stakeholders, including patients, providers, and insurers.